Antimicrobial RNases are small cationic proteins belonging to the vertebrate RNase A superfamily and endowed with a wide range of antipathogen activities. Vertebrate RNases, while sharing the active site architecture, are found to display a variety of noncatalytical biological properties, providing an excellent example of multitask proteins. The antibacterial activity of distant related RNases suggested that the family evolved from an ancestral host-defence function. The review provides a structural insight into antimicrobial RNases, taking as a reference the human RNase 3, also named eosinophil cationic protein (ECP). A particular high binding affi nity against bacterial wall structures mediates the protein action. In particular, the interaction with the lipopolysaccharides at the Gram-negative outer membrane correlates with the protein antimicrobial and specifi c cell agglutinating activity. Although a direct mechanical action at the bacteria wall seems to be suffi cient to trigger bacterial death, a potential intracellular target cannot be discarded. Indeed, the cationic clusters at the protein surface may serve both to interact with nucleic acids and cell surface heterosaccharides. Sequence determinants for ECP activity were screened by prediction tools, proteolysis and peptide synthesis. Docking results are complementing the structural analysis to delineate the protein anchoring sites for anionic targets of biological signifi cance.
Introduction: antimicrobial RNases
Antimicrobial RNases belong to the vertebrate-secreted RNase family, also called RNase A or pancreatic RNase superfamily (Beintema and Kleineidam , 1998 ) . The family gathers all the vertebrate RNases homologous to RNase A, where RNase A refers to the bovine pancreatic RNase, probably the best studied enzyme during the 20th century (Cuchillo et al. , 2011 ) . The protein was one of the fi rst enzymes discovered (1920) and crystallized (1939) . The enzyme was easily obtained from bovine pancreas at slaughterhouses, and at the beginning of the 1940s, 1 kg of purifi ed protein was obtained and made available for researchers. Its abundance, small molecular weight and high stability converted this protein as one of the favourites of the early 20th century biochemists. It was the fi rst enzyme whose primary structure was known, and in 1972, three Nobel prizes were awarded for their work. Pioneering sequencing provided around 40 homologous sequences of ruminants and other mammals, setting the basis for evolution studies. It was proposed that the pancreatic RNase would digest the huge amount of RNA in the stomach of ruminants produced by the intestinal fl ora. Together with a primary role in RNA digestion ascribed for RNase A, a variety of non-catalytical biological properties were described for the other family members. The quest in trying to fi nd out the family physiological role was just starting, and despite the joined efforts, the puzzle is not fully solved. The antibacterial activity of distantly related RNases suggested that ancestral RNases were in fact host-defence RNases (Cho and Zhang , 2007 ; Pizzo and D ' Alessio, 2007 ; Rosenberg , 2008b ) .
The RNase A family is strictly restricted to vertebrates and includes eight human members that maintain the active site residues (Cho et al. , 2005 ) , referred to as the ' canonical RNases ' (Sorrentino , 2010 ) (Figure 1 , Table 1 ). Although the primary sequence identity in some cases is as low as 30 % , they all share a common overall three dimensional structure with three to four conserved disulphide bonds and equivalent catalytic residues. The conserved catalytic triad is comprised of two histidines (H12 and H119 in RNase A) that participate by a general acid-basic mechanism in the cleavage of the RNA 3 ′ 5 ′ phosphodiester bond and one lysine (K41 in RNase A) that stabilises the transition state intermediate. Together with the RNase catalytic activity, other biological activities have been described for some family members Rosenberg , 2008b ) . In particular, several human RNases display a toxicity for several pathogens, and a role in host defence is proposed (Table 1) . However, trying to defi ne structural determinants for the so-called ' antimicrobial RNases ' is not straightforward. No unique structural identity patterns distinguish the ' antimicrobial ' members from the others. As a general rule, the antimicrobial RNases would work as small cationic bullets, which are secreted locally and mostly exert a cytotoxic action on a wide range of targets. Conserved amino acids in all sequences are boxed in black. The specifi c side chain-interacting residues identifi ed in docking analysis (see Tables S1-S4 ) are highlighted by coloured boxes: residues interacting with nucleotide probes are in blue, residues interacting with heparin probes are in orange and common residues are in green. Residues that interact with sulphate anions in ECP crystal complex structure (4A2O. pdb) are labelled with black stars at the bottom. The alignment was performed using Clustal W , and the picture was drawn using the ESPript program ( http://espript.ibcp.fr/ESPript/ ).
Their RNase activity participates in some of their cytotoxic power, but frequently, protein denaturation or ablation of active residues does not abolish their antipathogen activities (Pizzo and D ' Alessio, 2007 ) . Overall, the eight human RNases comply the main common properties of antimicrobial peptides, with a positive net charge that would enable them to interact electrostatically with the negatively charged phospholipids of the bacterial membrane and the lipolysaccharides or teichoic acids at the Gram-negative and -positive surface, having a high percentage of hydrophobic amino acids, and regions that can adopt amphipatic secondary structures upon membrane interaction . However, although all the family members share common structural patterns, only some of them have been reported to display antimicrobial activity (see Table 1 ). Moreover, antimicrobial RNases, as do many other antimicrobial proteins, may combine membrane lytic and cytotoxic actions together with other immunomodulatory properties Bystrom et al. , 2011 ; Nakatsuji and Gallo , 2012 ) .
A suggestive hypothesis regards antimicrobial RNases not as bactericidal proteins per se, but rather as a mere source of antimicrobial peptides. The proteins would act as a reservoir of active peptides (Pizzo and D ' Alessio, 2007 ; Pizzo et al. , 2008 ; Rosenberg , 2008b ; Giancola et al. , 2011 ; Sanchez et al. , 2011 ) . This proposal relies on the observation that some antimicrobial proteins retain their activity or are only active when denatured (During et al. , 1999 ; Schroeder et al. , 2011 ) . The secreted RNases could have a primary role linked to its RNase activity and secondarily would constitute a source of antimicrobial peptides, which could intervene when secreted at the infectious focus. There are also many examples in the literature of antimicrobial proteins that are activated in situ by specifi c proteolysis (Levy , 2000 ) . In fact, the proteolytic processing is used extensively in immunology cascade events. A local cleavage can release the active peptides in the infection area in the same manner as cecropin is released from cathelicidins expressed in neutrophils (Zanetti et al. , 1995 ; Burton and Steel , 2009 ) , lactoferricin is derived from the N-terminus (Krieg et al. , 1998 ; Clark et al. , 2003 ) ; Tyr33 nitration (Ulrich et al. , 2008 ) Host defense against viral infections; chemotaxis for dendritic cells (Rosenberg , 2008a ) RNase 3 (tested against several Gram-negative and -positive species (Torrent et al. , 2009b (Torrent et al. , , 2011b Arg97/Thr (related to asthma propensity and disease-induced pathologies) (Eriksson et al., 2007a; Adu et al. , 2011 ) Gly103Arg 3 potential N-glycosylation sites; 10 purifi ed variants of N-linked glycosylated forms (Eriksson et al. , 2007b ) ; N-glycosylation processed upon secretion by activated eosinophils (Woschnagg et al. , 2009 );
Tyr33 nitration (Ulrich et al. , 2008 ) Host defense against parasite, viral and bacterial infections; immunomodulation (Venge et al., 1999; Boix et al., 2008; Rosenberg, 2008b; Bystrom et al. , 2011 ) (Hooper et al. , 2003 ; Abtin et al. , 2009 ) Multiple substitutions related to amyotrophic lateral sclerosis (ALS9) (Greenway et al. , 2006 ) Pyro-Glu (N-terminal Gln cyclation) (Strydom et al. , 1985 ) Angiogenesis; cell differentiation; host defense ? (Moenner et al. , 1994 ; Strydom , 1998 ; Hooper et al. , 2003 ; Gao and Xu , 2008 ) RNase 6 (RNase K6)
Strong expression in lung, followed by heart, placenta, kidney, pancreas, liver, brain and skeletal muscle. Also expressed in monocytes and neutrophils None Arg66/Gln 2 potential N-glycosylation sites (Rosenberg and Dyer , 1996 ) Host defense ? ; RNA catabolism ? (Dyer et al. , 2004 ; Rosenberg and Dyer , 1996 ) Only natural variants in the mature protein reported in the UniProtKB are included. Table 1 (Continued) of lactoferrin (Nibbering et al. , 2001 ) by action of pepsin in the stomach or cryptdins are expressed in a precursor form and secreted by Paneth cells (Ayabe et al. , 2002 ) . Another example is lysozyme endowed with a specifi c muramidase activity together with a mechanical lytic action at the bacteria wall, which is retained when denatured (Masschalck et al. , 2001 ) . Lysozyme and RNases, as small cationic proteins, which are easy to purify, are indeed long travel companions recently recovered from the past as potential multitask effectors in innate immunity (Nakatsuji and Gallo , 2012 ) .
In particular, in the RNase A family, we fi nd a direct experimental evidence of a protein, the zebrafi sh RNase, that releases an antimicrobial peptide when processed in vivo by a bacterial protease (Zanfardino et al. , 2010 ) . Another family-related RNase, the leukocyte chicken RNase, can provide derived peptides that retain most of the parental protein activity (Nitto et al. , 2006 ) . RNase 3, the eosinophil cationic protein (ECP) is also offering an interesting example: the enzymatic protein proteolysis of ECP with a lysyl-endopeptidase produces a unique active segment corresponding to the N-terminus 1 -38 fragment (Sanchez et al. , 2011 ) . Interestingly, human ECP shows a single Lys in all its coding sequence (Lys 38). All other Lys residues in ECP lineage diverging from a common eosinophil RNase ancestor have been lost during evolution in detriment of Arg residues, which ultimately would have conferred the protein with the highest pI amongst the family counterparts. However, lysyl-endopeptidases are only reported in bacteria species, and no evidence is available from any in vivo processing of the eosinophil-secreted ECP. In any case, further scanning analysis using chemical cleavage and synthetic peptides confi rms that an N-terminus peptide can reproduce most of the protein antimicrobial properties (Torrent et al. , 2009b ; Sanchez et al. , 2011 ) . In the following section, we will try to address the structure-function relationship of antimicrobial RNases, taking ECP as a reference.
The eosinophil cationic protein (ECP) in host defence
The human RNase 3, or ECP, is an RNase specifi cally expressed in eosinophils and secreted during infection and infl ammation processes (Venge et al. , 1999 ; Bystrom et al. , 2011 ) . ECP levels can be detected in circulating blood (Venge et al. , 1977 ) , and its levels are routinely used to monitor asthma and other infl ammatory diseases (Blanchard and Rothenberg , 2009 ; Bystrom et al. , 2011 ) . Eosinophil traffi c and specifi c degranulation have been located in diverse pathological conditions, and a host-defence role for ECP at the respiratory and intestinal mucosa is attributed (Bystrom et al. , 2011 ) .
ECP, as an eosinophil granule secretion protein, is a key mediator against parasite infections, as helminths and protozoa (Tischendorf et al. , 1996 ; Boix et al. , 2008 ; Bystrom et al. , 2011 ; Malik and Batra , 2012 ) . Recent genomic studies revealed a polymorphism at the coding sequence (Arg97Thr), which correlates with asthma predisposition and parasitic infection susceptibility (Eriksson et al. , 2007a ) . Indeed, eosinophilia and specifi c eosinophil tissue infi ltration are directly associated with parasite infections (Klion and Nutman , 2004 ; Bystrom et al. , 2011 ; Makepeace et al. , 2012 ) . ECP toxicity was reported against helminths, as Schistosoma mansoni (Mclaren et al. , 1984 ; Ackerman et al. , 1985 ) and Brugia malayi (Hamann et al. , 1990 ) , and protozoa, as Leishmania (Elshafi e et al. , 2011 ; Singh and Batra , 2011 ) , Trypanosoma (Kierszenbaum et al. , 1986 ) and Plasmodium (Waters et al. , 1987 ) . Eosinophils are activated during Plasmodium infection (Kurtzhals et al. , 1998 ) , and the secreted protein participates in the parasite killing inside infected erythrocytes (Waters et al. , 1987 ) . Plasmodium falciparum infection induces eosinophilia, and ECP levels are increased during acute malaria (Kurtzhals et al. , 1998 ) . Unfortunately, the eosinophil protein is not only involved in the host defence against infection but also in the disease pathogenesis. A severe pathology is attributed to the protein neurotoxicity, which causes cerebral malaria, a major cause of children ' s death at an early stage. The natural variant (Arg97Thr), which reduces the protein cytotoxicity ), seems to have been selected in the Ghana population exposed to malaria infection, as a mechanism to avoid the protein severe neurotoxic side effects (Adu et al. , 2011 ) . A similar scenario was reported for Schistosoma infection, a common helminth parasite in tropical areas. Eosinophils participate not only in the host protection against schistosomes but also contribute to the derived pathogenesis, as fi brosis development and also the non-toxic variant would have been selected (Eriksson et al. , 2007a ) .
Together with the well-documented involvement of eosinophils in parasitic infection, ECP levels are also increased in viral (Kristjansson et al. , 2005 ) and bacterial infection (Venge et al. , 1978 ; Karawajczyk et al. , 1995 ; Niehaus et al. , 2000 ; Ashitani et al. , 2003 ) , and a specifi c eosinophil activation is reported in bacterial infection (Kvarnhammar and Cardell , 2012 ) . Although the direct contribution of eosinophils in bacterial infection is not so well established, many references in the literature indicate that this cell type complements signifi cantly the neutrophil ' s role during host defence. Besides, ECP is also secondarily expressed in activated neutrophils (Monteseirin et al. , 2007 ) . In fact, the protein discovery was closely followed by the description of its antimicrobial properties (Gleich et al. , 1986 ; Gabay et al. , 1989 ) . Preliminary work on eosinophil granules proteins already highlighted the high bactericidal activity of purifi ed ECP on Escherichia coli and Staphylococcus aureus (Lehrer et al. , 1989 ) . Interestingly, the RNase catalytic site was found to be not required for the protein bactericidal activity (Rosenberg , 1995 ) , and the protein toxicity is dependent on a direct action at the bacteria wall and cytoplasmic membrane levels (Torrent et al. , 2007 . Site-directed mutagenesis studies identifi ed the main critical residues exposed at the protein surface involved in membrane lysis and cytotoxicity (Carreras et al. , 2003 ; Torrent et al. , 2007 ; Singh and Batra , 2011 ) . Additionally, complementary studies on the protein native posttranslational forms and comparison of polymorphism variants highlighted the contribution of glycosylation on the protein cytotoxic power (Trulson et al. , 2007 ; Rubin et al. , 2009 ; Woschnagg et al. , 2009 ). In the following section, we detail the current knowledge on ECP antimicrobial properties.
Dissecting ECP antimicrobial mechanism of action
Currently, amongst the diverse reported antipathogen ECP activities, the bactericidal activity is one of the most extensively documented. Table 2 tries to compile all the experimental data that have contributed to defi ne the main protein active regions, and the location of the protein key motives is illustrated in Figure 2 . The Figure highlights the residues involved in the protein antimicrobial activity (Carreras et al. , 2003 ; Torrent et al. , 2009b Torrent et al. , , 2011b Singh and Batra , 2011 ) together with the defi ned RNase catalytic site (Rosenberg , 1995 ; Mohan et al. , 2002 ) . In particular, the N-terminus domain (1 -45) includes the main determinants for the protein antimicrobial activity (Torrent et al. , 2009b (Torrent et al. , , 2011b , and this region encompasses a stretch required for the protein selfaggregation and the bacteria agglutinating activity (Torrent et al. , 2010b (Torrent et al. , , 2011b Pulido et al. , 2012 ) . Taking into consideration the amino acid conservation in the context of the RNase A superfamily pylogenetic tree ( Figure S1 ), the family-conserved catalytic groove stands out among ECP-specifi c residues related to the antimicrobial activity, as the colouring conservation score shows off (Figure 3 ) .
By scanning the protein sequence using a prediction software based on an antimicrobial propensity scale (Torrent et al. , 2012 ) , an active domain at the N-terminus was identifi ed (Torrent et al. , 2009b ) . To further delimitate the protein key active regions and with a more biotechnological perspective, a structure-minimisation strategy was applied, to select the best pharmacophore candidate. The parental 1 -45 peptide was prone at both the N-and C-terminus ends, and the two key helical stretches were further linked with a connector, which provides fl exibility to the construct. The best fi nal analogue (6 -17) -(23 -36) represents a 40 % size reduction and can mostly reproduce the antimicrobial activity of the parental protein (Torrent et al. , 2011b ) (Table 3 ) . NMR spectroscopy and dynamic light scattering confi rmed that the fi nal construct adopted the same helical conformation with a higher structuration degree upon incubation on a membranelike environment (Torrent et al. , 2011b ) .
Another interesting feature of ECP antimicrobial action relies on its particular bacteria-agglutinating activity (Torrent et al. , 2010a ) , which was observed to be Gram-negative specifi c by testing several representative species (Torrent et al. , 2011b ) (see Table 3 ). Interestingly, a hydrophobic patch required for the protein self-aggregation mediates the protein ability to aggregate liposomes (Torrent et al. , 2010b ) and agglutinate bacterial cells. When scanning the eight human RNases with an aggregation prediction software (Conchillo -Sole et al., 2007 ), a unique hydrophobic patch (8 -16) is identifi ed in ECP (Figure 2) , which is not present in the other homologue sequences. The Ile13Ala substitution breaks the aggregationprone sequence, and the 1 -19 peptide, corresponding to the fi rst α helix, can form amyloid-like aggregates (Torrent et al. , 2010b ) . Indeed, switching off the protein self-aggregation propensity by a single amino acid substitution abolishes the protein cell agglutination activity and impairs the antimicrobial activity (Torrent et al., unpublished results). Figure 2 Representation of ECP three-dimensional structure showing the key regions and main residues identifi ed to be involved in the protein biological properties. Picture was drawn with PYMOL (DeLano Scientifi c). Amino acid sequences were aligned using Clustal W taking human ECP as a reference (sequence information and their phylogenetic relationship is included in Figure S1 ). The three-dimensional structure shows the residues coloured by their conservation score using the colour-coding bar at the bottom image. Residues were coloured in yellow when not enough information was available. Conserved residues belonging to the RNase catalytic site are labelled in pink, and the residues most specifi c to ECP are labelled in blue.
ECP bacteria-agglutinating activity was also correlated with the protein ability to interact with the Gram-negative outer membrane lipopolysaccharide (LPS) structure by using a battery of E. coli cells with progressively truncated LPS . Results indicated that the protein requires for a full antimicrobial activity both the LPS sugar core and the anionic phosphate groups, the agglutination activity being hampered by LPS truncation, mostly when the full core is removed. LPS-binding determinants were proposed by docking simulation, and residues Arg 1, Trp 10, Gln 14, Lys 38 and Gln 40 were spotted at hydrogenbonding distance from the phosphorylated saccharide moiety anchored to the Lipid A portion. The data would correspond to the previous region identifi ed to be involved in LPS binding using synthetic peptides (Torrent et al. , 2009b (Torrent et al. , , 2011b . Moreover, the YRWR (33 -36) tag alone attached to the protein C-terminus provides the human pancreatic RNase 1 with Gram-negative specifi c bactericidal activity (Torrent et al. , 2009a ). The results ' interest scope goes beyond the RNase A family. Finding the structural determinants for LPS recognition is a cherished goal for the pharmaceutical industry (Frecer et al. , 2004 ; Kaconis et al. , 2011 ) . LPS released by bacteria during infection can induce septic shock, and LPS binders are indeed excellent candidates to neutralise the induction of proinfl ammatory cytokines and modulate the host immune response (Gutsmann et al. , 2010 ; Brandenburg et al. , 2011 ; Pulido et al. , 2012 ) .
The last but not the least, ECP cytotoxicity can also target the human host tissues (Navarro et al. , , 2010 , contributing to undesired pathological side effects concomitant to eosinophil degranulation at the infection focus (Venge et al. , 1999 ; Bystrom et al. , 2011 ) . Cell surface glycosaminoglycan (GAGs) recognition is one of the fi rst steps that would mediate the protein toxicity to host cells (Fuchs and Raines , 2006 ) . In particular, heparin and heparan sulphate are the main heterosaccharides exposed at the extracellular matrix (Capila and Linhardt , 2002 ) . ECP shows a high binding affi nity to heparin and inhibits the enzyme RNase activity (Torrent et al. , 2011a ) . Critical residues involved in the interaction were identifi ed by molecular docking (Torrent et al. , 2011a ) and NMR spectroscopy (Garc í a-Mayoral et al., 2010 ) and corroborated by mutagenesis studies (Fan et al. , 2008 ) . In particular, the 33 -38 stretch is involved in ECP binding to GAGs ( Figure  2 ) (Fan et al. , 2008 ; Torrent et al. , 2011a ) . The protein interaction with heparan sulphate at the matrix of epithelial cells would facilitate the protein endocytosis (Fan et al. , 2007 ) . Further insight on the protein residues potentially involved in heparin binding has been deduced by molecular docking as detailed below.
Exploring ECP binding sites
Molecular docking simulations using sulphated heterosaccharides and nucleotide templates were performed to correlate the diverse biological properties of ECP with its binding site structure. Molecular modelling was carried out previously (Torrent et al. , 2011a ) using the Autodock software (The Scripps Research Institute, La Jolla, CA, USA) as detailed in the supplemental material. Protein complexes for all eight human RNases were predicted in the presence of dimeric and tetrameric structures for nucleotide and heparin targets. CpA and ApTpApA nucleotides where chosen as representative putative RNA substrates, and the IdoA (2S) GlcNS (6S) (5S) disaccharide and the corresponding tetramer were selected as heparin main components. Tables S1-S4 show each probe molecule details and collect all the protein and ligand atoms at a hydrogen bond distance for the eight human RNases. Overall comparison of the RNase binding mode confi rmed the contribution of equivalent protein recognition regions for most of the studied templates. Ligand binding mostly relies on interactions between protein polar and cationic residues and anionic groups, as nucleotide phosphates and heparin sulphates and carboxylates do. Overall, all tested ligands are located at the main protein catalytic groove. As an example, Figure 4 depicts the surface electrostatic representation of ECP structure and Atoms corresponding to the ApTpApA nucleotide are coloured in green, red, blue, white and orange for carbon, oxygen, nitrogen, hydrogen, and phosphate atoms, respectively. IdoA(2S) GlcNS (6S)-IdoA(2S) GlcNS (6S) heparin tretramer atoms are coloured in yellow, red, blue, white and orange for carbon, oxygen, nitrogen, hydrogen, and sulphate atoms, respectively.
illustrates the overlapping of both nucleotide and saccharide tetramers. We have highlighted the residues potentially involved in hydrogen bond interactions in the RNase sequence alignment (Figure 1) . The data reveal that many nucleotide and sugar-binding residues are overlapping in most studied RNases, although a more tight binding is predicted for the heparin target. Most of the spotted residues are related either to the RNase catalytic groove or to the protein N-terminus region. To analyse the RNase binding site architecture, we have followed the reference nomenclature for RNase A where pn, Bn and Rn designates the subsites assigned to phosphate, base and ribose units, p1 being the position where the RNA phosphodiester bond is cleaved (Raines , 1998 ; Cuchillo et al. , 2011 ) . Docking results confi rm that protein regions involved in both nucleotide and sugar binding (labelled in blue and orange, respectively, in the fi gure alignment) are mostly overlapping. In particular, the residues belonging to the main p1 nucleotide substrate binding site, that is, Gln 11, His 12, Lys 41 and His 119 for the pancreatic RNase, are conserved in all the predicted complexes (common residues shared for both targets are labelled in green). Besides, complementary interactions would facilitate the sugar binding at α 1 and the connecting loop between α 2 and β 1 (labelled in orange). These regions correspond to the previously assigned p-1 and p2 sites, which are fl anking the main p1 (Nogues et al. , 1998 ) .
A closer detailed inspection was carried out for ECPbinding pattern. A side by side comparison of RNase A-binding mode to the ApTpApA tetranucleotide, as reported in the crystal structure by Fontecilla-Camps and co-workers (Fontecilla -Camps et al., 1994 ) , with the predicted tetranucleotide complex for ECP (Figure 5 ), indicates that while most phosphate groups are located at equivalent positions, the orientations of the nucleotide bases differ signifi cantly. Moreover, phosphate-conserved binding sites are indeed matching the sulphate sites as defi ned in the ECPsulphate crystal complex (4A2O.pdb; Boix et al., 2012 ) (see residues labelled by stars in the sequence alignment). Besides, the sulphate-binding sites identifi ed in ECPsulphate crystal structure are shown to match the position of the sulphate groups of the heparin tetramer, as depicted in Figure 6 . Three main sulphate-binding sites have been defi ned for ECP (S1-S3) , where S1 and S2 overlap with the previously ascribed phosphate sites deduced from the crystal complex with 2 ′ 5 ′ ADP (Mohan et al. , 2002 ) , while Arg 1 and Arg 7 would correspond to an exposed anchoring region at the protein N-terminus defi ning the sulphate S3 site. In fact, side by side comparison of ECP-2 ′ 5 ′ ADP crystal structure and heparindisaccharide predicted complex shows equivalent key residues at S1 and S2 sites, together with the S3 site that would enhance the probe binding (Figure 7 ) . Interestingly, S1 and S2 sites were also reported for the other eosinophil RNase [RNase 2 or eosinophil-derived neurotoxin (EDN)] from protein-sulphate crystal complexes (Mosimann et al. , 1996 ; Swaminathan et al. , 2002 ) and nucleotide analogue complexes (Leonidas et al. , 2001 ; Baker et al. , 2006 ) . Some of the residue contributions were confi rmed experimentally by site-directed mutagenesis and functional studies for both eosinophil RNases (Carreras et al. , 2003 (Carreras et al. , , 2005 Sikriwal et al. , 2007 Sikriwal et al. , , 2009 Singh and Batra , 2011 ) . In any case, although common traits are shared by the two eosinophil RNases, ECP diverged from its counterpart, acquiring an unusual cationicity, with a pI close to 11. Indeed ECP shows 19 Arg on its coding sequence, most of them recently incorporated during its divergent evolution from the other eosinophil RNase Zhang et al. , 1998 ) . Close inspection of the additional Arg residues, unique to ECP (Figure 3 ), suggests that their strategic location may enhance the binding of longer anionic polymers of biological signifi cance, as LPS and heparan sulphate, which could mediate the protein action in host defence. Additionally, the protein-sulphate complex (4A2O.pdb) identifi es other bound anions at unique Arg residues, namely, Arg 75, Arg 77 and Arg 104, also involved in the protein antipathogen activities (Carreras et al. , 2003 ; Singh and Batra , 2011 ) . To conclude, ECP structural analysis has contributed to defi ne the overall traits that assist the protein-binding mode to glycosaminoglycans and mediate the protein-cell attachment and its immunomodulating properties (Lortat -Jacob et al., 2002 ; Imberty et al. , 2007 ; Boix et al. , 2011 ) and, hence, provides information of general interest for structure-based drug design applications.
Conclusions
Structural analysis on ECP/RNase 3 defi nes the most relevant traits involved in the protein antimicrobial mechanism of action. The sequence determinants for ECP antimicrobial activity were mapped by applying predictive tools, proteolysis and experimental testing of synthetic peptides. Bactericidal activity was tested using representative Gram-positive and Gram-negative species, and a high binding affi nity for LPS was observed. Indeed, a bacteria-agglutinating activity is specifi c for Gram-negative strains, and mutant strains with progressively truncated LPS were recently screened to assess the protein binding to the LPS polysaccharide moiety as a priming step in the bacteria-agglutination process.
Complementary, comparative docking analysis using both nucleotide and heterosaccharide probes was applied to defi ne ECP-binding site architecture, in the context of the pancreatic RNase A family. The eight human members, with a low primary sequence identity, share a common three-dimensional fold. Together with the conserved catalytic triad, some variability is found for the residues involved in nucleotide secondary binding sites. Docking results and the analysis of ECP Figure 7 On the left, representation of ECP with the 2 ′ 5 ′ ADP nucleotide taken from the crystal structure complex 1H1H.pdb (Mohan et al. , 2002 ) . On the right, representation of the modelled complex for ECP with the heparin disaccharide IdoA(2S) GlcNS (6S) (5S). Amino acids side chains at hydrogen bond distance are shown in ball and sticks. Atom types are coloured in cyan, red, blue, white, orange and yellow for carbon, oxygen, nitrogen, hydrogen, phosphate and sulphate atoms, respectively. Docking was performed using Autodock v.4.2 as detailed in the supplemental material section.
crystal structure in complex with sulphate anions indicate that ECP would expose additional surface cationic clusters that would assist the protein anchoring to anionic heterosaccharide molecules, as LPS at the Gram-negative outer membrane and GAGs at the host cell extracellular matrix. The structural analysis unravels the protein key-binding motives that can modulate its role in innate immunity. The data provide the structural basis for ECP biological properties and can assist the design of inhibitors of the protein cytotoxicity to host tissues during infl ammation processes, together with the development, in a much wider context, of therapeutic agents, such as LPS binders or alternative antibiotics.
